Results 101 to 110 of about 16,628 (221)

Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis [PDF]

, 2017
Pamela F. Weiss, Rui Xiao, Timothy G. Brandon, Ilaria Pagnini, Tracey Wright, Timothy Beukelman, Esi Morgan-DeWitt, Chris Feudtner   +7 more
openalex   +1 more source

Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide

Revista Brasileira de Reumatologia
OBJETIVO: Elaborar recomendações para o tratamento da artrite reumatoide no Brasil. MÉTODO: Revisão da literatura com seleção de artigos baseados em evidência e opinião de especialistas da Comissão de Artrite Reumatoide da Sociedade Brasileira de ...
Licia Maria Henrique da Mota, Boris Afonso Cruz, Claiton Viegas Brenol, Ivanio Alves Pereira, Lucila Stange Rezende-Fronza, Manoel Barros Bertolo, Max Victor Carioca de Freitas, Nilzio Antonio da Silva, Paulo Louzada-Júnior, Rina Dalva Neubarth Giorgi, Rodrigo Aires Corrêa Lima, Geraldo da Rocha Castelar Pinheiro   +11 more
doaj  

Effect of a Benzylidene Derivative, Novel Antirheumatic Agent, on the Production of Tissue Inhibitor of Metalloproteinases.

, 1994
Koju Watanabe, Haruhisa Hayashi, Yo Mori
openalex   +2 more sources

Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?

Research and Practice in Thrombosis and Haemostasis
Janus kinase inhibitors (JAKis) have revolutionized the treatment landscape for various inflammatory and autoimmune diseases since their introduction in 2012. The expanded indications of JAKis have raised concerns about the associated risk of thrombosis,
Yachar Dawudi, Samuel Benarroch, Hélène Helfer, David M. Smadja, Isabelle Mahé   +4 more
doaj  

The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis

, 2018
Yu. V. Muravyev, L. A. Muravyevа
openalex   +2 more sources

Erythroid‐stimulating agents in VEXAS syndrome: A retrospective study from an Italian multicentre cohort

British Journal of Haematology, Volume 207, Issue 1, Page 273-277, July 2025.
E. Diral, C. Campochiaro, G. Furnari, F. Moretti, J. Ferrari, C. Elena, G. Battipaglia, S. Barbato, A. Vitale, M. Frigeni, F. Crisafulli, M. Frassi, C. Papayannidis, A. D. Romagnoli, C. Cattaneo, A. D'Ambrosio, E. Morsia, P. Musto, G. Rivoli, M. E. Dragani, C. Toffalori, G. M. Bergonzi, G. Scorpio, A. Tomelleri, M. T. Voso, C. Gurnari, L. Vago, L. Dagna, F. Ciceri   +28 more
wiley   +1 more source

2. Antirheumatic Agents, 2) Biological Agents

, 2012
Koichi Amano
openalex   +2 more sources

EFFECTS OF SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, BIOLOGICAL AGENTS, AND PSYCHOPHARMACOTHERAPY ON THE MENTAL DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS

, 2017
А. А. Abramkin, Т. А. Lisitsyna, D. Veltishchev, O. Seravina, O. Kovalevskaya, Е. Л. Насонов   +5 more
openalex   +2 more sources

Erratum to: Optimum use of disease-modifying and immunosuppressive antirheumatic agents during pregnancy and lactation [PDF]

, 1996
Rosalind Ramsey‐Goldman, Ellen Van Obberghen‐Schilling   +1 more
openalex   +1 more source

Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?

, 2014
Döndü Üsküdar Cansu, Sabri Güncan, Nazife Şule Yaşar Bilge, Timuçin Kaşifoğlu, Cengiz Korkmaz   +4 more
openalex   +2 more sources